Yong G Peng, MD, PhD, FASE, FASA - Research

Research at a glance

Top areas of exploration

Postoperative Complications , 5 publications
Aortic Valve , 4 publications
Hydrazones , 4 publications
Pyridazines , 4 publications

Research activity

39 publications

161 citations

Why is this important?

Active clinical trials

Phase 3 Trial of PROTHROMPLEX TOTAL for Reversal of Direct Oral Factor Xa Inhibitor-induced Anticoag

The aim of this study is to find out the effects of TAK-330 compared with four-factor prothrombin complex concentrate (4F-PCC) as part of standard treatment other than Prothromplex Total for anticoagulation reversal in participants treated with鈥�

Investigators: T. Everett Jones, Yong G Peng
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

My publications

39 publications

2017

Repeated Neonatal Sevoflurane Exposure-Induced Developmental Delays of Parvalbumin Interneurons and Cognitive Impairments Are Reversed by Environmental Enrichment.

Molecular neurobiology

鈥�

2017

Supplement of levosimendan to epinephrine improves initial resuscitation outcomes from asphyxial cardiac arrest.

BMC anesthesiology

鈥�

2016

Descending Aortic Stent Graft Collapse During Frozen Elephant Trunk Repair: Detection Using Invasive Blood Pressure Monitoring and Intraoperative Transesophageal Echocardiography.

Journal of cardiothoracic and vascular anesthesia

鈥�

2015

Effects of Electroacupuncture of Different Intensities on Energy Metabolism of Mitochondria of Brain Cells in Rats With Cerebral Ischemia-Reperfusion Injury

Chinese Journal of Integrative Medicine